How have task force members determined the threshold value of EuroSCORE II for an increased surgical risk in patients undergoing aortic valve interventions?

How have task force members determined the threshold value of EuroSCORE II for an increased... European Journal of Cardio-Thoracic Surgery 0 (2018) 1 LETTER TO THE EDITOR predicted mortality 1.93%). Leon et al. [4] in a prospective, randomized study How have task force members determined (2302 patients, with 81.3% of them with an STS score of between 4.0% and 8.0%, 30-day mortality 6.1% for TAVI, 8.0% for SAVR, P-value = 0.11) concluded the threshold value of EuroSCORE II for an that in intermediate-risk patients, TAVI was similar to SAVR with respect to the primary end point of death or disabling stroke at 2 years. Therefore, is it rational increased surgical risk in patients undergoing to favour TAVI over SAVR in all patients with an STS or EuroSCORE II value of aortic valve interventions? > _4%? Dusko Nezic*, Ivana Petrovic and Slobodan Micovic Clinic of Cardiac Surgery, Department of Cardiac Surgery, Dedinje REFERENCES Cardiovascular Institute, Belgrade, Serbia [1] Falk V, Baumgartner H, Bax J, DeBonis M, Hamm C, Holm PJ et al. 2017 Received 9 January 2018; accepted 27 February 2018 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017;52:616–64. Keywords: Guidelines � Valvular management � Risk analysis [2] Nezic D, Ragus T, Micovic S, Trajic S, Spasojevic Milin B, Petrovic I et al. Clinical performances of EuroSCORE II risk stratification model in Serbian We read with great interest the article by Falk et al. [1] regarding guidelines of cardiac surgical population: a single centre validation study including management strategies for an individual patient with a given valvular disease. 10048 patients. Vojnosanit Pregl 2017; doi: 10.2298/VSP170810172N. We do believe that the recommendation that favours transcatheter aortic valve [3] Arangalage D, Cimadevilla C, Alkhoder S, Chiampan A, Himbert D, Brochet E implantation (TAVI) versus surgical aortic valve replacement (SAVR) in patients et al. Agreement between the new EuroSCORE II, the logistic EuroSCORE with an European System for Cardiac Operative Risk Evaluation II (EuroSCORE) and the Society of Thoracic Surgeons score: implications for transcatheter value > _4% (increased surgical risk, according to the authors, Table 7. and table aortic valve implantation. Arch Cardiovasc Dis 2014;107:353–60. on page 631) needs further clarification and discussion. In particular, until re- [4] Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S et al. cently, no threshold value has been proposed for the EuroSCORE II to define Transcatheter or surgical aortic-valve replacement in intermediate risk high-risk patients [2]. To the best of our knowledge, Arangalage et al. [3] are the patients. N Eng J Med 2016;374:1609–20. only researchers who have searched for correspondence between borderline values of the Society of Thoracic Surgeons (STS) score and old logistic EuroSCORE for high-risk patients (> _10% and > _20%, respectively), which favour *Corresponding author. Clinic of Cardiac Surgery, Dedinje Cardiovascular Institute, TAVI, and for the EuroSCORE II. They proposed a threshold of > _7% for high-risk Milana Tepica 1, 11000 Belgrade, Serbia. Tel: +381-11-3601631/3601724; patients, which provided the best diagnostic value in their research cohort. In a fax: +381-11-2666392; e-mail: nezic@eunet.rs (D. Nezic). subanalysis of our patients [2] undergoing SAVR (979 patients), 950 patients had a EuroSCORE II of <10%, and mortality was as low as 1.47% (14 of 950, doi:10.1093/ejcts/ezy121 The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. Downloaded from https://academic.oup.com/ejcts/advance-article-abstract/doi/10.1093/ejcts/ezy121/4985708 by Ed 'DeepDyve' Gillespie user on 12 July 2018 LETTER TO THE EDITOR http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cardio-Thoracic Surgery Oxford University Press

How have task force members determined the threshold value of EuroSCORE II for an increased surgical risk in patients undergoing aortic valve interventions?

Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/how-have-task-force-members-determined-the-threshold-value-of-zDc5hW4KUr
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
ISSN
1010-7940
eISSN
1873-734X
D.O.I.
10.1093/ejcts/ezy121
Publisher site
See Article on Publisher Site

Abstract

European Journal of Cardio-Thoracic Surgery 0 (2018) 1 LETTER TO THE EDITOR predicted mortality 1.93%). Leon et al. [4] in a prospective, randomized study How have task force members determined (2302 patients, with 81.3% of them with an STS score of between 4.0% and 8.0%, 30-day mortality 6.1% for TAVI, 8.0% for SAVR, P-value = 0.11) concluded the threshold value of EuroSCORE II for an that in intermediate-risk patients, TAVI was similar to SAVR with respect to the primary end point of death or disabling stroke at 2 years. Therefore, is it rational increased surgical risk in patients undergoing to favour TAVI over SAVR in all patients with an STS or EuroSCORE II value of aortic valve interventions? > _4%? Dusko Nezic*, Ivana Petrovic and Slobodan Micovic Clinic of Cardiac Surgery, Department of Cardiac Surgery, Dedinje REFERENCES Cardiovascular Institute, Belgrade, Serbia [1] Falk V, Baumgartner H, Bax J, DeBonis M, Hamm C, Holm PJ et al. 2017 Received 9 January 2018; accepted 27 February 2018 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017;52:616–64. Keywords: Guidelines � Valvular management � Risk analysis [2] Nezic D, Ragus T, Micovic S, Trajic S, Spasojevic Milin B, Petrovic I et al. Clinical performances of EuroSCORE II risk stratification model in Serbian We read with great interest the article by Falk et al. [1] regarding guidelines of cardiac surgical population: a single centre validation study including management strategies for an individual patient with a given valvular disease. 10048 patients. Vojnosanit Pregl 2017; doi: 10.2298/VSP170810172N. We do believe that the recommendation that favours transcatheter aortic valve [3] Arangalage D, Cimadevilla C, Alkhoder S, Chiampan A, Himbert D, Brochet E implantation (TAVI) versus surgical aortic valve replacement (SAVR) in patients et al. Agreement between the new EuroSCORE II, the logistic EuroSCORE with an European System for Cardiac Operative Risk Evaluation II (EuroSCORE) and the Society of Thoracic Surgeons score: implications for transcatheter value > _4% (increased surgical risk, according to the authors, Table 7. and table aortic valve implantation. Arch Cardiovasc Dis 2014;107:353–60. on page 631) needs further clarification and discussion. In particular, until re- [4] Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S et al. cently, no threshold value has been proposed for the EuroSCORE II to define Transcatheter or surgical aortic-valve replacement in intermediate risk high-risk patients [2]. To the best of our knowledge, Arangalage et al. [3] are the patients. N Eng J Med 2016;374:1609–20. only researchers who have searched for correspondence between borderline values of the Society of Thoracic Surgeons (STS) score and old logistic EuroSCORE for high-risk patients (> _10% and > _20%, respectively), which favour *Corresponding author. Clinic of Cardiac Surgery, Dedinje Cardiovascular Institute, TAVI, and for the EuroSCORE II. They proposed a threshold of > _7% for high-risk Milana Tepica 1, 11000 Belgrade, Serbia. Tel: +381-11-3601631/3601724; patients, which provided the best diagnostic value in their research cohort. In a fax: +381-11-2666392; e-mail: nezic@eunet.rs (D. Nezic). subanalysis of our patients [2] undergoing SAVR (979 patients), 950 patients had a EuroSCORE II of <10%, and mortality was as low as 1.47% (14 of 950, doi:10.1093/ejcts/ezy121 The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. Downloaded from https://academic.oup.com/ejcts/advance-article-abstract/doi/10.1093/ejcts/ezy121/4985708 by Ed 'DeepDyve' Gillespie user on 12 July 2018 LETTER TO THE EDITOR

Journal

European Journal of Cardio-Thoracic SurgeryOxford University Press

Published: Apr 25, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off